by admin | Nov 25, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Terry Gross – NPR news Dr. Siddhartha Mukherjee still remembers the first cell he cultured: It was an immune cell from a mouse, and he had grown it in a petri dish. As he examined it through a microscope, the cell moved, and Mukherjee was fascinated....
by admin | Nov 21, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
The new model cells aid in the study of early embryonic development. by KU Leuven – SciTechDaily Professor Vincent Pasque and his colleagues at KU Leuven have used stem cells to create a new kind of human cell in the lab. The new cells closely mirror their...
by admin | Nov 20, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Markers of nerve damage fell significantly in most patients after transplant by Marisa Wexler – Multiple Sclerosis News Today Autologous hematopoietic stem cell transplant (aHSCT) reduces markers of nerve fiber and myelin damage in people with...
by admin | Nov 18, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Greg Slabodkin, ScienceBoard Editor in Chief The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies (OTAT) to a “Super Office” within the Center of Biologics Research and Evaluation (CBER) to meet its...
by admin | Nov 17, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
An experiment tests whether the gene-editing technology can stop the virus from replicating, which would ultimately wipe out the infection. By Wired.com In July, an HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to...
